Skip to main content
George Sakoulas, MD, Infectious Disease, San Diego, CA, Sharp Memorial Hospital

GeorgeSakoulasMD

Infectious Disease • San Diego, CA

Physician

Join to view full profile

Dr. Sakoulas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sakoulas' full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1999 - 2002
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1999
  • Harvard Medical School
    Harvard Medical SchoolClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • MA State Medical License
    MA State Medical License 1997 - 2012
  • NY State Medical License
    NY State Medical License 2002 - 2011
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Authored Content

  • Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
  • Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature, and Laboratory Evaluation of Potential Novel Antibiotic SynergiesJanuary 2018
  • Another Look at Antimicrobial Prophylaxis for Dental Procedures in Patients with Prosthetic Heart ValvesOctober 2017

Press Mentions

  • 04 Dec COVID-19: IVIG Reduced Progression to Ventilator and Shortened Hospital Stays in Sicker Patients
    04 Dec COVID-19: IVIG Reduced Progression to Ventilator and Shortened Hospital Stays in Sicker PatientsDecember 4th, 2020
  • Octapharma USA Presents Results of Investigational Use of Octagam® 10% for Severe COVID-19 Patients at ASH Annual Meeting
    Octapharma USA Presents Results of Investigational Use of Octagam® 10% for Severe COVID-19 Patients at ASH Annual MeetingDecember 2nd, 2020
  • Intravenous Immunoglobulin Significantly Reduces Respiratory Morbidity in COVID-19 Study Supported by Octapharma
    Intravenous Immunoglobulin Significantly Reduces Respiratory Morbidity in COVID-19 Study Supported by OctapharmaSeptember 9th, 2020
  • Join now to see all

Hospital Affiliations

Dr. George Sakoulas, Dr. George Sakoulas, MD, Dr. G Sakoulas